Can a new biomarker indicate whether or not a breast cancer will metastasize (spread to distant sites)?
-
-
One study that demonstrated our ability to remove only the sentinel node (here we assume no known disease in the nodes) and not performing the more invasive axillary node dissection was the International Breast Cancer Study Group (IBCSG) 23-01 trial. This study now updates its findings.
-
All right, I know I usually blog about health-related matters in the wellness realm. Today, I want to take a bit of a detour…
-
Researchers conducted a randomized clinical trial, examining the effects of a 16-week combined aerobic and resistance exercise intervention on metabolic syndrome, obesity, and blood markers among ethnically diverse, sedentary, overweight, or obese survivors of breast cancer.
-
A lower risk of breast cancer is found among older women who have greater levels of vitamin D, according to a study from the University of California, San Diego.
-
For women who have completed menopause, we often offer pills that target the estrogen creation pathway, using drugs known as aromatase inhibitors.
-
Here’s the idea: What if we could give you a pill that would cause cancer to light up upon exposure to infrared light?
-
As a radiation oncologist, I am challenged to provide personalized care in the setting of rapidly changing scientific evidence and treatment guidelines. For my colleagues in medical oncology, we have the added issue of new drug approvals. Can artificial intelligence (AI) clinical decision-support systems help address this challenge?
-
Body fat, not weight,heightens the risk of breast cancer.
-
Microbubbles may improve the sensitivity of cancer cells to radiation therapy and radioembolization.